China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Shares Shorted: Short Interest Down 96.1% in October

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 28,225 shares, a drop of 96.1% from the October 15th total of 721,044 shares. Based on an average daily trading volume, of 716,620 shares, the days-to-cover ratio is presently 0.0 days. Currently, 564.5% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Wall Street Zen raised shares of China SXT Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Saturday, October 31st. Weiss Ratings downgraded shares of China SXT Pharmaceuticals from a “sell (e+)” rating to a “sell (e)” rating in a report on Monday. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

China SXT Pharmaceuticals Stock Performance

NASDAQ:SXTC traded up $0.07 during trading hours on Thursday, reaching $2.90. The company had a trading volume of 23,482 shares, compared to its average volume of 69,711. The business’s 50-day simple moving average is $123.05 and its two-hundred day simple moving average is $11,976.65. China SXT Pharmaceuticals has a twelve month low of $2.71 and a twelve month high of $8,375,880.00. The company has a current ratio of 7.94, a quick ratio of 7.76 and a debt-to-equity ratio of 0.02.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc. is a pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicine (TCM) products. The company produces herbal formulations intended for use in the treatment and management of various health conditions, as well as products positioned for general wellness and health maintenance. Its product portfolio includes prescription medicines, over-the-counter medicines and dietary supplements. The company’s offerings are based on traditional Chinese medicinal practices and may be provided in forms such as herbal extracts, pills and other finished formulations.